Cantaloupe, Inc. - Preferred Stock
US ˙ OTCPK

Introduction

This page provides a comprehensive analysis of the known insider trading history of HEC Management GP LLC. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate HEC Management GP LLC has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CTLP / Cantaloupe, Inc. 10% Owner 9,270,694
US:TALK / Talkspace, Inc. 10% Owner 11,340,600
10% Owner 3,491
US:TVTY / Tivity Health Inc 10% Owner 0
US:CVRS / Corindus Vascular Robotics, Inc. 10% Owner 0
US:EGRX / Eagle Pharmaceuticals, Inc. Director 732,777
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by HEC Management GP LLC. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CTLPP / Cantaloupe, Inc. - Preferred Stock - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CTLPP / Cantaloupe, Inc. - Preferred Stock. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2022-05-25 CTLP Hudson Executive Capital LP 17,940 4.8300 17,940 4.8300 86,650 82 6.8300 35,880 41.41
2022-05-24 CTLP Hudson Executive Capital LP 59,305 4.4700 59,305 4.4700 265,093
2022-05-23 CTLP Hudson Executive Capital LP 66,215 4.5000 66,215 4.5000 297,968
2021-12-29 CTLP Hudson Executive Capital LP 20,000 7.9900 20,000 7.9900 159,800
2021-12-28 CTLP Hudson Executive Capital LP 55,281 8.0700 55,281 8.0700 446,118
2021-12-27 CTLP Hudson Executive Capital LP 31,354 8.1100 31,354 8.1100 254,281
2019-10-16 USAT Hudson Executive Capital LP 165,000 7.2636 165,000 7.2636 1,198,494
2019-10-14 USAT Hudson Executive Capital LP 80,000 6.7003 80,000 6.7003 536,024
2019-09-26 USAT Hudson Executive Capital LP 605,000 4.8650 605,000 4.8650 2,943,325
2019-09-25 USAT Hudson Executive Capital LP 1,176,000 4.4336 1,176,000 4.4336 5,213,914
2019-09-24 USAT Hudson Executive Capital LP 20,000 4.4000 20,000 4.4000 88,000
2019-09-23 USAT Hudson Executive Capital LP 143,200 4.4600 143,200 4.4600 638,672
2019-08-01 USAT Hudson Executive Capital LP 1,000,252 6.9300 1,000,252 6.9300 6,931,746

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CTLPP / Cantaloupe, Inc. - Preferred Stock Insider Trades
Insider Sales CTLPP / Cantaloupe, Inc. - Preferred Stock - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CTLPP / Cantaloupe, Inc. - Preferred Stock. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2023-02-21 CTLP Hudson Executive Capital LP 90,582 6.3000 90,582 6.3000 570,667 31 5.2200 -97,828 -17.14

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CTLPP / Cantaloupe, Inc. - Preferred Stock Insider Trades
Insider Purchases EGRX / Eagle Pharmaceuticals, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CTLPP / Cantaloupe, Inc. - Preferred Stock. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

EGRX / Eagle Pharmaceuticals, Inc. Insider Trades
Insider Sales EGRX / Eagle Pharmaceuticals, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CTLPP / Cantaloupe, Inc. - Preferred Stock. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

EGRX / Eagle Pharmaceuticals, Inc. Insider Trades
Insider Purchases HWAY / Themes ETF Trust - Themes US Infrastructure ETF - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CTLPP / Cantaloupe, Inc. - Preferred Stock. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HWAY / Themes ETF Trust - Themes US Infrastructure ETF Insider Trades
Insider Sales HWAY / Themes ETF Trust - Themes US Infrastructure ETF - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CTLPP / Cantaloupe, Inc. - Preferred Stock. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HWAY / Themes ETF Trust - Themes US Infrastructure ETF Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by HEC Management GP LLC as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-02-21 2023-02-21 4 CTLP CANTALOUPE, INC.
Common Stock
S - Sale -90,582 9,270,694 -0.97 6.30 -570,667 58,405,372
2024-02-21 2023-02-20 4 CTLP CANTALOUPE, INC.
Common Stock
J - Other -2,884,584 9,361,276 -23.56
2022-05-25 2022-05-25 4 CTLP CANTALOUPE, INC.
Common Stock
P - Purchase 17,940 12,245,860 0.15 4.83 86,650 59,147,504
2022-05-25 2022-05-24 4 CTLP CANTALOUPE, INC.
Common Stock
P - Purchase 59,305 12,227,920 0.49 4.47 265,093 54,658,802
2022-05-25 2022-05-23 4 CTLP CANTALOUPE, INC.
Common Stock
P - Purchase 66,215 12,168,615 0.55 4.50 297,968 54,758,768
2021-12-29 2021-12-29 4 CTLP CANTALOUPE, INC.
Common Stock
P - Purchase 20,000 12,102,400 0.17 7.99 159,800 96,698,176
2021-12-29 2021-12-28 4 CTLP CANTALOUPE, INC.
Common Stock
P - Purchase 55,281 12,082,400 0.46 8.07 446,118 97,504,968
2021-12-29 2021-12-27 4 CTLP CANTALOUPE, INC.
Common Stock
P - Purchase 31,354 12,027,119 0.26 8.11 254,281 97,539,935
2021-11-24 2021-11-23 4 TALK Talkspace, Inc.
Common Stock
P - Purchase 1,000,000 11,340,600 9.67 2.08 2,080,000 23,588,448
2021-10-26 2021-08-30 4 TALK Talkspace, Inc.
Common Stock
A - Award 15,384 15,384
2021-08-16 2021-08-16 4 TALK Talkspace, Inc.
Common Stock
P - Purchase 142,500 17,980,600 0.80 5.30 755,250 95,297,180
2021-08-16 2021-08-13 4 TALK Talkspace, Inc.
Common Stock
P - Purchase 46,000 17,838,100 0.26 5.23 240,580 93,293,263
2021-08-16 2021-08-12 4 TALK Talkspace, Inc.
Common Stock
P - Purchase 2,100 17,792,100 0.01 5.17 10,857 91,985,157
2021-07-02 3 TALK Talkspace, Inc.
Common Stock
5,150,000
2021-07-02 3 TALK Talkspace, Inc.
Common Stock
5,000,000
2021-05-14 2021-05-14 4 CTLP CANTALOUPE, INC.
Common Stock
A - Award 9,606 25,015 62.34
2021-03-11 2021-03-10 4 CATM Cardtronics plc
Restricted Stock Units
A - Award 3,491 3,491
2021-03-11 2021-03-09 4 CATM Cardtronics plc
Restricted Stock Units
M - Exercise -5,952 0 -100.00
2021-03-11 2021-03-09 4 CATM Cardtronics plc
Ordinary Shares
M - Exercise 5,952 14,040 73.59
2021-02-26 2021-02-24 4 USAT USA TECHNOLOGIES INC
Common Stock
A - Award 975,000 11,995,765 8.85 9.60 9,360,000 115,159,344
2020-07-02 2020-06-30 4 USAT USA TECHNOLOGIES INC
Common Stock
A - Award 635,593 11,020,765 6.12
2020-06-29 2020-06-26 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 24,200 8,652,968 0.28 23.30 563,860 201,614,154
2020-06-29 2020-06-26 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 145,800 8,628,768 1.72 22.45 3,273,210 193,715,842
2020-06-29 2020-06-25 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 1,520 8,482,968 0.02 24.75 37,620 209,953,458
2020-06-29 2020-06-25 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 98,480 8,481,448 1.17 24.09 2,372,383 204,318,082
2020-06-23 2020-06-23 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 75,350 8,374,880 0.91 24.34 1,834,019 203,844,579
2020-06-23 2020-06-19 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 100 8,299,530 0.00 23.24 2,324 192,881,077
2020-06-23 2020-06-19 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 133,474 8,299,430 1.63 23.74 3,168,673 197,028,468
2020-05-22 2020-05-21 4 USAT USA TECHNOLOGIES INC
Non-Qualified Stock Option (Right to Buy)
A - Award 120,000 120,000
2020-05-19 2020-05-15 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 39,023 8,165,956 0.48 18.94 739,096 154,663,207
2020-05-11 2020-05-07 4 TVTY TIVITY HEALTH, INC.
Long Put Option (right to sell)
D - Sale to Issuer -43,776 0 -100.00 0.60 -26,266
2020-05-11 2020-05-07 4 TVTY TIVITY HEALTH, INC.
Short Call Option (obligation to sell)
J - Other 43,776 0 -100.00 3.85 168,538
2020-05-11 2020-05-07 4 TVTY TIVITY HEALTH, INC.
Common Stock
D - Sale to Issuer -3,960,000 4,795,310 -45.23 12.20 -48,312,000 58,502,782
2020-05-08 2020-05-06 4 USAT USA TECHNOLOGIES INC
Common Stock
A - Award 15,409 15,409
2020-04-02 2020-03-31 4 CATM Cardtronics plc
Restricted Stock Units
A - Award 5,952 5,952
2020-03-13 3 TVTY TIVITY HEALTH, INC.
Common Stock
17,510,620
2020-03-13 3 TVTY TIVITY HEALTH, INC.
Common Stock
17,510,620
2020-03-13 3 TVTY TIVITY HEALTH, INC.
Common Stock
17,510,620
2020-03-13 3 TVTY TIVITY HEALTH, INC.
Common Stock
17,510,620
2020-03-13 3 TVTY TIVITY HEALTH, INC.
Common Stock
17,510,620
2020-03-11 2020-03-09 4 CATM Cardtronics plc
Restricted Stock Units
M - Exercise -4,278 0 -100.00
2020-03-11 2020-03-09 4 CATM Cardtronics plc
Ordinary Shares
M - Exercise 4,278 8,135,021 0.05
2020-03-06 2020-03-04 4 USAT USA TECHNOLOGIES INC
Long Put Option (right to sell)
J - Other 5,300 0 -100.00 0.70 3,710
2020-03-06 2019-08-05 4/A USAT USA TECHNOLOGIES INC
Short Put Option (obligation to buy)
S - Sale -5,300 5,300 -50.00 1.40 -7,420 7,420
2019-10-31 2019-10-29 4 CVRS Corindus Vascular Robotics, Inc.
Common Stock Purchase Warrant
D - Sale to Issuer -4,725,000 0 -100.00 4.28 -20,223,000
2019-10-31 2019-10-29 4 CVRS Corindus Vascular Robotics, Inc.
Series A-1 Preferred Stock
D - Sale to Issuer -105,281 0 -100.00 85.60 -9,012,072
2019-10-31 2019-10-29 4 CVRS Corindus Vascular Robotics, Inc.
Series A Preferred Stock
D - Sale to Issuer -540,000 0 -100.00 85.60 -46,224,000
2019-10-31 2019-10-29 4 CVRS Corindus Vascular Robotics, Inc.
Common Stock
D - Sale to Issuer -14,235,545 0 -100.00 4.28 -60,928,133
2019-10-31 2019-10-29 4 CVRS Corindus Vascular Robotics, Inc.
Common Stock
D - Sale to Issuer -106,219 0 -100.00 4.28 -454,617
2019-10-28 2019-10-25 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale X -15,437 732,777 -2.06 63.57 -981,302 46,581,315
2019-10-28 2019-10-24 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,494 748,214 -0.20 62.53 -93,412 46,782,155
2019-10-23 2019-10-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale X -200 749,708 -0.03 62.58 -12,516 46,916,727
2019-10-23 2019-10-22 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6,567 749,908 -0.87 62.68 -411,618 47,004,008
2019-10-23 2019-10-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,849 756,475 -0.51 62.56 -240,791 47,324,546
2019-10-18 2019-10-18 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,600 760,324 -0.21 62.61 -100,174 47,602,973
2019-10-18 2019-10-17 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale X -13,842 761,924 -1.78 62.58 -866,196 47,679,223
2019-10-18 2019-10-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale X -102 775,766 -0.01 62.50 -6,375 48,485,375
2019-10-16 2019-10-16 4 USAT USA TECHNOLOGIES INC
Common Stock
P - Purchase 165,000 10,385,172 1.61 7.26 1,198,494 75,433,735
2019-10-16 2019-10-14 4 USAT USA TECHNOLOGIES INC
Common Stock
P - Purchase 80,000 10,220,172 0.79 6.70 536,024 68,478,218
2019-10-15 2019-10-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,909 775,868 -0.50 62.63 -244,836 48,595,639
2019-10-15 2019-10-11 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale X -16,300 779,777 -2.05 60.39 -984,419 47,093,696
2019-10-15 2019-10-10 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7,829 796,077 -0.97 60.16 -471,002 47,892,948
2019-10-09 2019-10-08 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,558 803,906 -0.19 60.03 -93,520 48,254,860
2019-10-09 2019-10-07 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,901 805,464 -0.60 60.11 -294,600 48,416,522
2019-09-26 2019-09-26 4 USAT USA TECHNOLOGIES INC
Common Stock
P - Purchase 605,000 10,140,172 6.34 4.86 2,943,325 49,331,937
2019-09-26 2019-09-25 4 USAT USA TECHNOLOGIES INC
Common Stock
P - Purchase 1,176,000 9,535,172 14.07 4.43 5,213,914 42,275,139
2019-09-26 2019-09-24 4 USAT USA TECHNOLOGIES INC
Common Stock
P - Purchase 20,000 8,359,172 0.24 4.40 88,000 36,780,357
2019-09-23 2019-09-23 4 USAT USA TECHNOLOGIES INC
Common Stock
P - Purchase 143,200 8,339,172 1.75 4.46 638,672 37,192,707
2019-09-23 2019-09-19 4 USAT USA TECHNOLOGIES INC
Call Option (right to buy)
P - Purchase 12,500 12,500 0.50 6,250 6,250
2019-09-19 2019-09-17 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100 810,365 -0.01 60.00 -6,000 48,621,900
2019-09-13 2019-09-12 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale X -200 810,465 -0.02 60.07 -12,014 48,684,633
2019-09-13 2019-09-11 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,112 810,665 -0.14 60.06 -66,785 48,687,243
2019-08-05 2019-08-05 4 USAT USA TECHNOLOGIES INC
Short Put Option (obligation to buy)
S - Sale -5,300 5,300 -50.00 1.40 -7,420 7,420
2019-08-05 2019-08-01 4 USAT USA TECHNOLOGIES INC
Common Stock
P - Purchase 1,000,252 8,195,972 13.90 6.93 6,931,746 56,798,086
2019-05-20 3 USAT USA TECHNOLOGIES INC
Common Stock
14,391,440
2019-05-20 3 USAT USA TECHNOLOGIES INC
Common Stock
14,391,440
2019-05-20 3 USAT USA TECHNOLOGIES INC
Common Stock
14,391,440
2019-05-20 3 USAT USA TECHNOLOGIES INC
Common Stock
14,391,440
2019-05-20 3 USAT USA TECHNOLOGIES INC
Common Stock
14,391,440
2019-03-15 2019-03-13 4 CATM Cardtronics plc
Restricted Stock Units
A - Award 4,278 4,278
2019-03-14 2019-03-12 4 CVRS Corindus Vascular Robotics, Inc.
Common Stock
P - Purchase 2,899,391 14,235,545 25.58 1.38 4,000,000 19,639,358
2019-03-12 2019-03-08 4 CATM Cardtronics plc
Restricted Stock Units
M - Exercise -3,810 0 -100.00
2019-03-12 2019-03-08 4 CATM Cardtronics plc
Ordinary Shares
M - Exercise 3,810 8,130,743 0.05
2018-08-15 2018-08-13 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 54,898 8,126,933 0.68 29.89 1,640,901 242,914,027
2018-08-10 2018-08-10 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 12,350 8,072,035 0.15 30.22 373,217 243,936,898
2018-08-10 2018-08-08 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 12,850 8,059,685 0.16 29.73 382,030 239,614,435
2018-06-22 2018-06-20 4 CATM Cardtronics plc
Restricted Stock Units
A - Award 3,810 3,810
2018-05-04 2018-05-03 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 24,000 8,046,835 0.30 25.34 608,160 203,906,799
2018-05-04 2018-05-02 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 119,000 8,022,835 1.51 25.32 3,013,080 203,138,182
2018-04-30 2018-04-27 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 122,150 7,903,835 1.57 25.92 3,166,128 204,867,403
2018-04-30 2018-04-26 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 85,000 7,781,685 1.10 25.87 2,198,950 201,312,191
2018-04-24 2018-04-20 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 350,500 7,696,685 4.77 25.39 8,899,195 195,418,832
2018-04-13 2018-04-11 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 958,355 7,346,185 15.00 23.55 22,569,260 173,002,657
2018-04-02 2018-03-29 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 63,100 6,387,830 1.00 22.47 1,417,857 143,534,540
2018-03-20 3 CVRS Corindus Vascular Robotics, Inc.
Common Stock
22,672,308
2018-03-20 3 CVRS Corindus Vascular Robotics, Inc.
Common Stock
22,672,308
2018-03-20 3 CVRS Corindus Vascular Robotics, Inc.
Common Stock
22,672,308
2018-03-20 3 CVRS Corindus Vascular Robotics, Inc.
Common Stock
22,672,308
2018-02-23 2018-02-21 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 5,810 6,324,730 0.09 24.00 139,440 151,793,520
2018-02-23 2018-02-21 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 278,402 6,318,920 4.61 23.39 6,511,823 147,799,539
2018-02-23 2018-02-21 4 CATM Cardtronics plc
Ordinary Shares
P - Purchase 37,788 6,040,518 0.63 22.73 858,921 137,300,974
2018-01-31 3 CATM Cardtronics plc
Ordinary Shares
12,005,460
2018-01-31 3 CATM Cardtronics plc
Ordinary Shares
12,005,460
2018-01-31 3 CATM Cardtronics plc
Ordinary Shares
12,005,460
2018-01-31 3 CATM Cardtronics plc
Ordinary Shares
12,005,460
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)